Barbara Goodfriend, 83, opted for medical aid in dying after being diagnosed with ALS. The New Jersey widow ended her life in ...

Masitinib is an oral inhibitor of tyrosine kinases, enzymes important for immune cells thought to drive ALS inflammation and ...

Kadimastem’s attempt to vault onto Nasdaq is picking up momentum, with shareholders signing off on a merger with NLS Pharmaceutics that would enable the cell therapy developer to recover from last ...

Salt Lake City-based pharmaceutical company Clene Inc. has amended its grant subaward with Columbia University, securing up ...

Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.

Qure (QURE) announced that the Independent Data Monitoring Committee for EPISOD1, uniQure’s Phase I/II clinical trial of AMT-162, an ...

MAID is currently legal in 10 states and Washington, D.C., but eight other states are considering similar laws this year.

Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...

Jazz compositions and charity coalesce in The Mingus Awareness Project. Since 2007, the project has provided opportunities for musicians to perform new arrangements of works by the venerated bassist, ...

Western student applying occupational therapy to her ALS experience to help other families manage their daily lives with physical or cognitive impairment.